DAGYNIL 1.25mg price in UAE

Overview

Welcome to Dwaey, specifically on DAGYNIL 1.25mg Tablets page.
This medicine contains an important and useful components, as it consists of Oestrogens (conjugated).
DAGYNIL 1.25mg is available in the market in concentration 1.25mg/Tablet and in the form of Tablets.

DAGRA PHARMACEUTICALS is the producer of DAGYNIL 1.25mg and it is imported from NETHERLANDS, The most popular alternatives of DAGYNIL 1.25mg are listed downward .

Mode Of Action

Acemetacin is the glycolic acid ester of indometacin. It inhibits cyclooxygenase and hence prevents the formation of prostaglandins which are involved in the inflammation process.

Indication

Rheumatoid arthritis
Osteoarthritis
Lower back pain
Ankylosing spondylitis
Post-operative pain
Musculoskeletal and joint pain

Precaution

Elderly; allergic disorders/coagulation defects; epilepsy; parkinsonism; psychiatric disturbances (prolonged therapy may require ophthalmic and blood examinations); renal, hepatic or cardiac impairment.

Side Effects

Headaches
dizziness
GI disturbances; anaemia; acute interstitial nephritis; corneal deposits
retinal disturbances; rash
urticaria; alopoecia; CHF
tachycardia
arrhythmias
palpitations; jaundice. Potentially Fatal: Toxic hepatitis
Stevens-Johnson syndrome.

Contra indication

Previous/active peptic ulcers; hypersensivity to aspirin/NSAIDs; severe liver disease; neonates with untreated infection, children, pregnancy, lactation.

Pregnancy and lactation

Interaction

May reduce the antihypertensive effect of beta-blockers. May prolong bleeding when used with acenocoumarol. Increased risk of convulsion when used with quinolone. Concurrent use with aspirin, NSAIDs, SSRIs or corticosteroids may increase risk of GI bleeding. May increase serum levels of ciclosporin. May increase serum levels of lithium. Potentially Fatal: Increased risk of methotrexate toxicity when used together.